- Home
- OTTR vs APLS Comparison
OTTR vs APLS Comparison
Compare OTTR & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTTR
- APLS
- Stock Information
- Founded
- OTTR 1907
- APLS 2009
- Country
- OTTR United States
- APLS United States
- Employees
- OTTR N/A
- APLS N/A
- Industry
- OTTR Electric Utilities: Central
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- OTTR Utilities
- APLS Health Care
- Exchange
- OTTR Nasdaq
- APLS Nasdaq
- Market Cap
- OTTR 3.3B
- APLS 2.9B
- IPO Year
- OTTR N/A
- APLS 2017
- Fundamental
- Price
- OTTR $77.22
- APLS $21.47
- Analyst Decision
- OTTR
- APLS Buy
- Analyst Count
- OTTR 0
- APLS 20
- Target Price
- OTTR N/A
- APLS $33.35
- AVG Volume (30 Days)
- OTTR 172.3K
- APLS 3.0M
- Earning Date
- OTTR 11-03-2025
- APLS 10-30-2025
- Dividend Yield
- OTTR 2.72%
- APLS N/A
- EPS Growth
- OTTR N/A
- APLS N/A
- EPS
- OTTR 6.79
- APLS 0.36
- Revenue
- OTTR $1,311,540,000.00
- APLS $1,016,397,000.00
- Revenue This Year
- OTTR $0.41
- APLS $24.62
- Revenue Next Year
- OTTR $4.72
- APLS N/A
- P/E Ratio
- OTTR $11.37
- APLS $59.95
- Revenue Growth
- OTTR N/A
- APLS 42.11
- 52 Week Low
- OTTR $71.66
- APLS $16.10
- 52 Week High
- OTTR $88.36
- APLS $35.72
- Technical
- Relative Strength Index (RSI)
- OTTR 40.96
- APLS 37.31
- Support Level
- OTTR $76.95
- APLS $23.85
- Resistance Level
- OTTR $78.61
- APLS $30.48
- Average True Range (ATR)
- OTTR 1.30
- APLS 1.67
- MACD
- OTTR 0.14
- APLS -0.47
- Stochastic Oscillator
- OTTR 44.44
- APLS 19.70
About OTTR Otter Tail Corporation
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.